Intrinsic Value

Cyclerion Therapeutics, Inc. (CYCN)

$3.04

+0.13 (+4.47%)

Enterprise Value -27.66
Net Debt -7.57
Equity Value -20.09
Shares Outstanding 2.34
Equity Value Per Share -8.59



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt